We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Del. Jury Finds Flexus Took Incyte Secrets, Nixes Damages

Law360 (November 8, 2018, 6:23 PM EST) -- A Delaware jury agreed Wednesday that Flexus Biosciences Inc. and two top officers misappropriated cancer drug trade secrets from Incyte Corp., but rejected unjust enrichment claims that could have rung up...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.